Detalhe da pesquisa
1.
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
N Engl J Med
; 387(21): 1957-1968, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346079
2.
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis.
Hepatology
; 77(4): 1348-1365, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971873
3.
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.
Gut
; 72(7): 1385-1398, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36697207
4.
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta.
J Hepatol
; 79(3): 657-665, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120031
5.
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
J Hepatol
; 79(2): 576-580, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030400
6.
Beyond bulevirtide: Alternative therapeutic options for the management of hepatitis delta virus.
J Viral Hepat
; 30 Suppl 1: 33-38, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529713
7.
Prognostic value of genotyping in hepatocellular carcinoma: A systematic review.
J Viral Hepat
; 30(7): 582-587, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922710
8.
Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
Am J Gastroenterol
; 117(2): 253-263, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34913875
9.
COVID-19-associated hepatic artery pseudoaneurysms.
Liver Int
; 42(8): 1907-1908, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748622
10.
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
BMC Infect Dis
; 22(1): 94, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086481
11.
COVID-19: Discovery, diagnostics and drug development.
J Hepatol
; 74(1): 168-184, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33038433
12.
Hepatitis D Virus Infection.
N Engl J Med
; 389(1): 58-70, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407002
13.
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
N Engl J Med
; 378(4): 354-369, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365309
14.
EASL-ALEH 2015 algorithm for the use of transient elastography in treatment-naive patients with hepatitis B: An independent validation.
J Viral Hepat
; 28(8): 1169-1176, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002927
15.
New therapies for hepatitis delta virus infection.
Liver Int
; 41 Suppl 1: 30-37, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34155804
16.
Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-life.
Liver Int
; 41(7): 1509-1517, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33999515
17.
Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
Dig Dis Sci
; 66(3): 881-898, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303953
18.
Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development.
J Hepatol
; 73(2): 409-422, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333923
19.
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
J Hepatol
; 73(6): 1434-1445, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615276
20.
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet
; 393(10179): 1453-1464, 2019 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765123